Fidia Remains Market Leader as Medtronic Trails Behind: Stringent Regulations in the EU Orthopedic Biomaterials Market
VANCOUVER, BRITISH COLUMBIA, CANADA , May 30, 2022 /EINPresswire.com/ -- iData Research, a global consulting and market research firm, has just released exclusive research on the European orthopedic biomaterials market, addressing key insights and consequences of COVID-19 in 2021, 2022, and beyond. One major limiter influencing nearly all segments within the 15 European orthopedic biomaterials markets is stringent regulations and lengthy health assessment processes. In Europe, medical devices must undergo a strict conformity assessment to demonstrate that they meet the legal requirements ensuring they are safe and effective.
According to iData's European Market Report for Orthopedic Biomaterials, the market was valued at €550 million in 2021. This is expected to increase over the forecast period to reach $632 million by 2028. This report includes procedure numbers by indication, unit sales, average selling prices, market drivers and limiters, competitive market share analysis, and more.
iData's analysis includes detailed segmentation on the following markets including bone graft substitutes, which are represented by allografts, demineralized bone matrix (DBM) and synthetic bone grafts. The report also includes orthopedic growth factors, cell therapies, hyaluronic acid (HA) viscosupplementation and cartilage repair.
Among the many competitors in the orthopedic biomaterials market, Fidia and Medtronic are the top two market share leaders. Fidia retained its spot as the leader within the European orthopedic biomaterials market. This is due to its orthopedic HA viscosupplementation products, Hyalubrix® and Hyalgan®, which maintains a strong presence in the market.
To accurately estimate market shares, units sold, average selling prices, product segments, and brands as well as procedural volumes, iData Research uses its proprietary market and procedure databases, as well as hospital purchase order data to complement its primary and secondary research initiatives.
Follow the link below to download a Free Research Summary of the European Orthopedic Biomaterials Market Report:
https://idataresearch.com/product/european-orthopedic-biomaterials-market/
For Further Information
More insights like this can be found in the latest reports by iData. Please email us at info@idataresearch.net or register online for a brochure and synopsis.
About iData
iData Research is an international consulting and market research firm dedicated to empowering confident strategic decisions within the medical device, dental, and pharmaceutical industries.
Emma Matrick
iData Research
+1 604-266-6933
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
